Standout Papers

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism 2007 2026 2013 2019 1.8k
  1. Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism (2009)
    Sam Schulman, Clive Kearon et al. New England Journal of Medicine
  2. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial (2007)
    Bengt I. Eriksson, Ola E. Dahl et al. The Lancet
  3. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial (2007)
    Bengt I. Eriksson, O.E. Dahl et al. Journal of Thrombosis and Haemostasis
  4. Oral Thrombin Inhibitor Dabigatran Etexilate vs North American Enoxaparin Regimen for Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery (2008)
    Jeffrey S. Ginsberg, Bruce L. Davidson et al. The Journal of Arthroplasty
  5. Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial (2021)
    Milton Packer, Javed Butler et al. Circulation
  6. Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction (2021)
    Javed Butler, Milton Packer et al. European Heart Journal

Immediate Impact

6 by Nobel laureates 10 from Science/Nature 82 standout
Sub-graph 1 of 15

Citing Papers

Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial
2022 Standout
SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
2022 Standout

Works of Janet Schnee being referenced

Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction
2021 Standout
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial
2021 Standout

Author Peers

Author Last Decade Papers Cites
Janet Schnee 4750 3967 647 1113 41 6.0k
Dominique Mottier 2691 3383 372 1270 138 5.3k
Corinne Frère 2421 1129 317 1291 118 4.2k
Ulf Angerås 2225 1770 113 931 39 3.9k
Melina Verso 1592 2439 250 689 59 3.5k
Urszula Masiukiewicz 1853 1447 1932 1017 21 4.0k
Richard C. Becker 3730 1603 217 1464 78 5.4k
Franco Piovella 3198 4598 105 1821 90 6.1k
Michael Gould 2839 3642 82 1606 41 5.8k
L. Bara 2263 1049 1254 943 72 4.1k
Steven R. Steinhubl 6757 1998 546 3593 104 7.8k

All Works

Loading papers...

Rankless by CCL
2026